Chemotherapy-induced mucositis: The role of gastrointestinal microflora and mucins in the luminal environment

Andrea M. Stringer, Rachel J. Gibson, Joanne M. Bowen, Richard M. Logan, Ann S.J. Yeoh, Dorothy M.K. Keefe

Research output: Contribution to journalReview articlepeer-review

72 Citations (Scopus)

Abstract

Collectively, mucositis refers to the damage caused to the mucous membranes of the body following cytotoxic cancer therapy. Diarrhea is one such manifestation of mucositis and is a common side effect of chemotherapy that remains poorly understood. It affects the entire gastrointestinal tract. The exact number of patients affected by diarrhea as a result of treatment is uncertain, although it is believed that approximately 10% of patients with advanced cancer will be affected. Despite advances in the understanding of oral and small intestinal mucositis over recent years, large intestinal mucositis, including diarrhea, has not been well defined, and the underlying mechanisms of the condition have yet to be established. The majority of the literature concerning diarrhea is based on clinical observations, with little basic research. However, from the research conducted, it is likely that the intestinal microflora play a role in the development of chemotherapy-induced diarrhea. This review will examine in detail what is known about the mechanisms of chemotherapy-induced diarrhea and will explore the potentially important relationship among intestinal microflora, the luminal environment, and the subsequent development of chemotherapy-induced diarrhea.

Original languageEnglish
Pages (from-to)259-267
Number of pages9
JournalJournal of Supportive Oncology
Volume5
Issue number6
Publication statusPublished - Jun 2007
Externally publishedYes

Fingerprint

Dive into the research topics of 'Chemotherapy-induced mucositis: The role of gastrointestinal microflora and mucins in the luminal environment'. Together they form a unique fingerprint.

Cite this